tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IMVT is currently covered by 8 analysts with an average price target of $42.69. This is a potential upside of $10.65 (33.24%) from yesterday's end of day stock price of $32.04.
Immunovant's activity chart (see below) currently has 176 price targets and 182 ratings on display. The stock rating distribution of IMVT is 57.14% BUY and 42.86% HOLD.
Analysts average stock forecasts to be materialized ratio is 54.35% with an average time for these price targets to be met of 189 days.
Highest price target for IMVT is $62, Lowest price target is $28, average price target is $42.69.
Most recent stock forecast was given by BRIAN CHENG from JPMORGAN on 04-Aug-2026. First documented stock forecast 07-Jan-2020.
Currently out of the existing stock ratings of IMVT, 12 are a BUY (57.14%), 9 are a HOLD (42.86%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2024
$50
$16.38 (48.72%)
$34
2 months 4 days ago
(04-Aug-2026)
4/7 (57.14%)
$10.64 (27.03%)
238
Buy Since 25-Apr-2023
$61
$27.38 (81.44%)
$58
3 months 8 days ago
(30-Jun-2026)
2/7 (28.57%)
$22.47 (58.32%)
100
Buy Since 23-May-2023
$62
$23.15 (59.59%)
$44
4 months 12 days ago
(26-May-2026)
3/10 (30%)
$28.17 (83.27%)
119
Hold Since 14-Oct-2025
$30
$-8.85 (-22.78%)
$22
4 months 16 days ago
(22-May-2026)
4/6 (66.67%)
$-4.15 (-12.15%)
431
Buy Since 29-Jul-2020
$40
$1.15 (2.96%)
$35
4 months 17 days ago
(21-May-2026)
15/25 (60%)
$5.87 (17.20%)
271
What is IMVT (Immunovant) average time for price targets to be met?
Which analyst most recently updated their price target on IMVT (Immunovant)?
Which analyst has the most public recommendations on IMVT (Immunovant)?
Which analyst is the currently most bullish on IMVT (Immunovant)?
Which analyst is the currently most reserved on IMVT (Immunovant)?
